Company Shared Poster on Breakthrough Genetic Stratification Data from Positive Phase 2b OLIVE Trial Results for BH-200MUNICH ...
People are looking to AI for friendship, therapy, and even love. But AI models are incapable of having emotions because they ...
Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric ...
In a useful entry in the growing canon of “quit lit,” Charles Knowles blends science and memoir to persuade readers to cut down on alcohol.
"Neumora’s Alzheimer’s disease agitation drug shows early success in Phase Ib trial" was originally created and published by ...
When you’ve tried and failed to lose weight and feel better for years, it’s easy to lose faith in your ability to do so ...
Detailed price information for Neumora Therapeutics Inc (NMRA-Q) from The Globe and Mail including charting and trades.
When stripped of its myths, sensible love is not passionless, painless or passive. In fact, it is an emotionally intelligent ...
University of California, Davis, Chancellor Gary S. May has named Professor Karen Bales as director of the California ...
NMRA-511 demonstrated a 15.7 reduction on mean CMAI total score, representing a clinically meaningful effect NMRA-511 demonstrated unsurpassed clinical effect size on CMAI total score in a pre-specifi ...
Investing.com -- Die Aktie von Neumora Therapeutics Inc (NASDAQ:NMRA) legte am Montag um 6,9 % zu, nachdem das biopharmazeutische Unternehmen positive Ergebnisse seiner Phase-1b-Studie mit dem ...
Obwohl die Studie nicht darauf ausgelegt war, statistische Signifikanz nachzuweisen, berichtete Neumora von positiven Tendenzen des Medikaments. Bessere Ergebnisse wurden in einer vordefinierten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback